Lam Research (LRCX) Tops Q3 EPS by 4c, Offers Guidance

Lam Research (NASDAQ: LRCX) reported Q3 EPS of $1.04, $0.04 better than the analyst estimate of $1.00. Revenue for the quarter came in at $4.72 billion versus the consensus estimate of $4.63 billion.

GUIDANCE:

Lam Research sees Q4 2025 EPS of $1.10-$1.30, versus the consensus of $0.98. Lam Research sees Q4 2025 revenue of $4.7-5.3 billion, versus the consensus of $4.59 billion.

For earnings history and earnings-related data on Lam Research (LRCX) click here.

You May Also Be Interested In

• McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
• Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook